South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom 
Thailand Inflation Remains Negative for 10th Straight Month in January 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals 
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off 
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 
Olympus Corp CEO Resigns Following Allegations
Olympus Corp, the renowned Japanese endoscope manufacturer, announced on Monday that Chief Executive Officer Stefan Kaufmann has resigned after allegations surfaced regarding his purchase of illegal drugs. This development has caused a 6% decline in the company's shares, marking the steepest drop in nearly three months.
Kaufmann, a German national, took over the CEO role in April 2023 intending to enhance Olympus's medical equipment division. He succeeded Yasuo Takeuchi, who had successfully navigated the company through extensive asset sales during his tenure.
In a company statement, Olympus disclosed that upon receiving the allegations against Kaufmann, it promptly consulted with external legal counsel and launched an investigation. The investigation's findings led the Board of Directors to unanimously conclude that Kaufmann likely engaged in behavior contrary to the company's global code of conduct and core values.
Kaufmann, 56, was asked to resign and complied with the request. As Olympus grapples with this latest scandal, Yasuo Takeuchi will temporarily reassume the CEO role.
The impact of Kaufmann's departure was evident in the stock market, as Olympus shares have seen a notable increase of 35% over the past year, outperforming the Nikkei 225 index, which rose by 24%.
This incident is not Olympus's first encounter with controversy; thirteen years ago, former CEO Michael Woodford exposed significant accounting fraud involving inflated acquisition costs to conceal financial losses. Woodford's subsequent firing sparked a turbulent battle for control of the company.
